Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
37.61 USD | +0.48% | +2.00% | +2.58% |
04-12 | Barclays Cuts Price Target on Edgewell Personal Care to $37 From $39, Maintains Equalweight Rating | MT |
03-07 | Razor maker Harry's files for IPO, sources say | RE |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analyst opinion has improved significantly over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company is in debt and has limited leeway for investment
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.58% | 1.87B | B | ||
+10.05% | 381B | C- | ||
+8.03% | 129B | B- | ||
-16.39% | 62.59B | A- | ||
+0.22% | 52.86B | B+ | ||
-11.98% | 36.11B | - | ||
+2.76% | 33.57B | B- | ||
+9.68% | 17.29B | A- | ||
+7.68% | 14.75B | B | ||
-9.06% | 10.82B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- EPC Stock
- Ratings Edgewell Personal Care Company